1. 1) Collins, R., Peto, R., MacMahon, S., Hebert, P., Fiebach, N. H., Eberlein, K. A., Godwin, J., Qizilbash, N., Taylor, J. O., & Hennekens, C. H. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure : overview of randomised drug trials in their epidemiological context. Lancet,(1990), 335, 827-838.
2. 2) van Baak, M. A., Struyker Boudier, A. J., & Smits, J. F. M. Antihypertensive mechanisms of beta-adrenoreceptor blockade : a review. Clin. Exp. Hypertens.,(1985), A7, 1-72.
3. 3) Wallin, B. G., Sundlof. G., Stromgren. E., & Aberg, H. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension,(1984), 6, 557-562.
4. 4) Cook, J. R., Bigger, J. T., Kleiger, R. E., Fleiss, J. L., Steinman, R. C., & Rolnitzky, L. M. Effect of atenolol and diltiazem on heart period variability in normal persons. J. Am. Coll. Cardiol.,(1991), 17, 480-484.
5. 5) Niemeia, M. J., Airaksinen, K. E. J., & Huikuri, H. V. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J. Am. Coll. Cardiol.,(1994), 23, 1370-1377.